Articles

Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Division of Hematology, ASST Papa Giovanni XXIII, Bergamo
Division of Hematology, San Gerardo Hospital, Monza
Division of Hematology, A.O. Spedali Civili, Brescia
Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome
SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino
Division of Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan
Hematology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan
Hematology and Clinical Immunology, Department of Medicine, Azienda Ospedaliera di Padova, Padova
Division of Hematology, ASST Papa Giovanni XXIII, Bergamo
University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padova
Division of Hematology, Ospedale di Circolo and Fondazione Macchi, University of Insubria, Varese
Division of Hematology and Stem Cell Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milan
Humanitas Clinical and Research Center, IRCCS, Milan
Division of Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan
Hematology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Department of Molecular Medicine, University of Pavia, Pavia
Department of Molecular Medicine, University of Pavia, Pavia
Department of Molecular Medicine, University of Pavia, Pavia
Clinical Epidemiology and Biostatistics Service, Fondazione IRCCS Policlinico San Matteo, Pavia
Clinical Epidemiology and Biostatistics Service, Fondazione IRCCS Policlinico San Matteo, Pavia
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia
Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome
Haematologica Early view Oct 6, 2022 https://doi.org/10.3324/haematol.2022.281342